A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...

Delgocitinib is the first FDA-approved topical JAK inhibitor for moderate to severe chronic hand eczema in adults. The DELTA 1 and DELTA 2 studies showed significant efficacy, with improved patient ...

Treatment options for severe chronic hand eczema are limited and carry troublesome adverse effects. Delgocitinib cream had superior efficacy compared with oral alitretinoin for this patient population ...

Targeted treatments have emerged as a safer and more effective option for eczema patients, but high costs remain a barrier.

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Living with eczema affects more than just the skin – it influences everything from sleep patterns to clothing choices and social interactions. This inflammatory skin condition, which comes from a ...

Eczema is an umbrella term for several skin conditions that cause areas to become red, itchy, and inflamed. Eczema in young children is usually the type called atopic dermatitis. It’s believed to ...

While babies’ skin is typically considered to be smooth, hydrated and, well, baby-soft, this isn’t always the case. In fact, at least one in five children has eczema (a condition that causes the skin ...

Nektar Therapeutics (NASDAQ:NKTR) is one of the best hot stocks to buy according to Wall Street analysts. On June 24, Nektar Therapeutics announced positive results from its mid-stage REZOLVE-AD study ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...